2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow ECRI bv: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion Evolocumab - Coronary Artery Disease | Phase 4 | Withdrawn | ECRI bv | 2019-08-30 | 2019-12-06 | |
| A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planning and Execution of Surgical Revascularization in Patients With Complex Coronary Artery Disease, Based Solely on MSCT Imaging Utilizing GE Healthcare Revolution CT and HeartFlow FFRCT. Multi-sliced computed tomography (MSCT) - Multivessel Coronary Artery Disease | Phase 4 | Withdrawn | ECRI bv | 2019-06-28 | 2019-12-06 |
evolocumab (1)
Belgium (1) · Germany (1) · Italy (1) · Switzerland (1)